MHIVF yields 2500.00% · PFE yields 6.13%● Live data
📍 MHIVF pulled ahead of the other in Year 1
Combined, MHIVF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MHIVF + PFE for your $10,000?
Invesque Inc. operates as a health care real estate investment company. Its portfolio includes investments in independent living, assisted living, memory care, skilled nursing, transitional care, and medical office properties. As of March 11, 2022, the company owned a portfolio of 88 properties, including 60 assisted living and memory care facilities, 12 skilled nursing facilities, 10 transitional care properties, and 4 medical office buildings in the United States; and 15 properties comprised 11 medical office buildings, and 4 seniors housing and care facilities in Canada. It also includes investments in owner occupied seniors housing properties, which comprise the ownership of real estate properties, as well as provides management services. The company was formerly known as Mainstreet Health Investments Inc. and changed its name to Invesque Inc. in January 2018. Invesque Inc. was incorporated in 2007 and is headquartered in Toronto, Canada.
Full MHIVF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.